FDA post-market surveillance system enters next phase

A national system that uses electronic healthcare data to monitor the safety of FDA-regulated drugs and medical products is being enhanced to increase its efficiency and responsiveness.


More for you

Loading data for hdm_tax_topic #better-outcomes...